Marianne M Martinic

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Prognostic Factors

Rheumatoid Arthritis

Top Venues

Arthritis research & therapy

Journal of immunology (Baltimore, Md. : 1950)

Idorsia Pharmaceuticals Ltd.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Idorsia Pharmaceuticals Ltd. Dec 04 2017

Switzerland

Senior Director :: Immunology Pharmacology

Publications

Daniel S Strasser, Sylvie Froidevaux, Virginie Sippel, Estelle Gerossier, Ursula Grieder, Gabin M Pierlot, Andrea Kieninger-Gräfitsch, Enrico Vezzali, Anna K Stalder, Bérengère Renault, Jesper Ryge, Aaron Hart, Ulrich Mentzel, Peter M A Groenen, Marcel P Keller, Marten Trendelenburg, Marianne M Martinic, Mark J Murphy
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus. RMD open 6 (2) (2021)
Estelle Gerossier, Saba Nayar, Sylvie Froidevaux, Charlotte G Smith, Celine Runser, Valentina Iannizzotto, Enrico Vezzali, Gabin Pierlot, Ulrich Mentzel, Mark J Murphy, Marianne M Martinic, Francesca Barone
Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome. Arthritis research & therapy 23 (1) (2021)
Marianne M Martinic, Irina Caminschi, Meredith O'Keeffe, Therese C Thinnes, Raelene Grumont, Steve Gerondakis, Dianne B McKay, David Nemazee, Amanda L Gavin
The Bacterial Peptidoglycan-Sensing Molecules NOD1 and NOD2 Promote CD8+ Thymocyte Selection. Journal of immunology (Baltimore, Md. : 1950) 198 (7) (2017)